It is estimated that seven million Americans misuse or abuse prescription drugs, a situation described as an ‘epidemic’. Although accurate data about the scale of the problem have been hard to obtain in the UK, both the House of Commons Home Affairs Committee and the …
Articles: 25.05 5 March 2014
Lower respiratory tract infections in the community lead to considerable morbidity and days off work. Our Drug review considers the assessment of disease severity, when to prescribe antibiotics and recommended management of LRTIs, followed by sources of further information.
Diagnosis and management of lower respiratory tract …
Steve Chaplin describes what specials are, who manufactures them and how the introduction of Drug Tariff specials in 2011 has led to a reduction in costs.
How Drug Tariff specials have reduced prescribing costs
Topical steroids are the mainstay of treatment in atopic dermatitis, but 60–80 per cent patients or carers have an aversion to using them due to the potential side-effects. Here, the authors discuss topical steroid phobia and the importance of communication in its management.
How to reassure …
Clinical guideline. Osteoarthritis: care and management in adults. This update to the 2008 guideline includes changes to decision-making and referral thresholds for surgery, and new recommendations about diagnosis and follow-up.
New from NICE
The risk of developing serious pneumonia in patients with COPD is doubled with fluticasone, with higher doses having a greater risk. The risk was increased only minimally with budesonide.
Risk of serious pneumonia in COPD patients using inhaled corticosteroids
In our series on the history of prescribing policy, Dr Darrin Baines traces how successive governments have attempted to curb drug costs. Here, he describes the recommendations made by the Merrison and Greenfield reports and the introduction of the Limited List.
The Merrison and Greenfield reports …